Gill Rachel B, Frederick Samuel L, Hartline Caroll B, Chou Sunwen, Prichard Mark N
Department of Pediatrics, University of Alabama School of Medicine, Birmingham, AL, USA.
Virol J. 2009 Jan 21;6:9. doi: 10.1186/1743-422X-6-9.
The UL97 kinase has been shown to phosphorylate and inactivate the retinoblastoma protein (Rb) and has three consensus Rb-binding motifs that might contribute to this activity. Recombinant viruses containing mutations in the Rb-binding motifs generally replicated well in human foreskin fibroblasts with only a slight delay in replication kinetics. Their susceptibility to the specific UL97 kinase inhibitor, maribavir, was also examined. Mutation of the amino terminal motif, which is involved in the inactivation of Rb, also renders the virus hypersensitive to the drug and suggests that the motif may play a role in its mechanism of action.
UL97激酶已被证明可磷酸化视网膜母细胞瘤蛋白(Rb)并使其失活,且具有三个可能促成该活性的共有Rb结合基序。在Rb结合基序中含有突变的重组病毒通常能在人包皮成纤维细胞中良好复制,只是复制动力学稍有延迟。还检测了它们对特异性UL97激酶抑制剂马立巴韦的敏感性。参与Rb失活的氨基末端基序发生突变,也会使病毒对该药物高度敏感,这表明该基序可能在其作用机制中发挥作用。